Search Results - "Mohty, Bilal"

Impact of gene mutations on treatment response and prognosis of acute myeloid leukemia secondary to myeloproliferative neoplasms by Venton, Geoffroy, Courtier, Frédéric, Charbonnier, Aude, D'incan, Evelyne, Saillard, Colombe, Mohty, Bilal, Mozziconacci, Marie‐Joëlle, Birnbaum, Daniel, Murati, Anne, Vey, Norbert, Rey, Jérôme

“…Acute myeloid leukemias secondary (sAML) to myeloproliferative neoplasms (MPN) have variable clinical courses and outcomes, but remain almost always fatal…”
Get full text

Peripheral neuropathy and new treatments for multiple myeloma: background and practical recommendations by MOHTY, Bilal, EL-CHEIKH, Jean, YAKOUB-AGHA, Ibrahim, MOREAU, Philippe, HAROUSSEAU, Jean-Luc, MOHTY, Mohamad

“…In multiple myeloma, peripheral neuropathy has for a long time been considered as mainly secondary to the plasma cell dyscrasia itself. With the advent of new…”
Get full text

Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients by Ljungman, Per, de la Camara, Rafael, Perez-Bercoff, Lena, Abecasis, Manuel, Nieto Campuzano, Jose Bartolo, Cannata-Ortiz, M Jimena, Cordonnier, Catherine, Einsele, Hermann, Gonzalez-Vicent, Marta, Espigado, Ildefonso, Halter, Jörg, Martino, Rodrigo, Mohty, Bilal, Sucak, Gülsan, Ullmann, Andrew J, Vázquez, Lourdes, Ward, Katherine N, Engelhard, Dan

“…During 2009, a new strain of A/H1N1 influenza appeared and became pandemic. A prospective study was performed to collect data regarding risk factors and…”
Get full text

Treatment of post transplant relapse of FLT3-ITD mutated AML using 5-azacytidine and sorafenib bitherapy by Sid, Selim, Jerome, Rey, Aude, Charbonnier, Evelyne, D’Incan, Bilal, Mohty, Didier, Blaise, Vey, Norbert

Get full text

PB1844: REAL: A RETROSPECTIVE STUDY OF THE CLINICO‐BIOLOGICAL FEATURES OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES PATIENTS INCLUDED IN AN EARLY PHASE TRIAL AT A COMPREHENSIVE CANCER CENTER by Berton, Guillaume, Vicier, Cécile, Hospital, Marie‐Anne, Saillard, Colombe, Hicheri, Yosr, Maisano, Valerio, Villetard, Ferdinand, Rouzaud, Camille, Corda, Evelyne D’incan, Rey, Jerome, Mohty, Bilal, Charbonnier, Aude, Proux, Aurelien, Vey, Norbert, Goncalves, Anthony, Garciaz, Sylvain

Get full text

Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients by MOHTY, Bilal, BEL, Michael, PASSWEG, Jakob, SIEGRIST, Claire-Anne, ROOSNEK, Eddy, VUKICEVIC, Marija, NAGY, Monika, LEVRAT, Emmanuel, MEIER, Sara, GRILLET, Stephane, COMBESCURE, Christophe, KAISER, Laurent, CHALANDON, Yves

“…Responses to influenza vaccines are poorly characterized in immunocompromised patients. The goal of this study was to assess the efficacy of the…”
Get full text

Tandem autologous-allogeneic stem cell transplantation as a feasible and effective procedure in high-risk lymphoma patients by Crocchiolo, Roberto, Castagna, Luca, Garciaz, Sylvain, Fürst, Sabine, El Cheikh, Jean, Sarina, Barbara, Bramanti, Stefania, Granata, Angela, Vai, Andrea, Harbi, Samia, Morabito, Lucio, Mohty, Bilal, Giordano, Laura, Devillier, Raynier, Coso, Diane, Balzarotti, Monica, Chabannon, Christian, Carlo-Stella, Carmelo, Santoro, Armando, Bouabdallah, Reda, Blaise, Didier

Get full text

Antithymocyte Globulin in Reduced-Intensity Conditioning Regimen Allows a High Disease-Free Survival Exempt of Long-Term Chronic Graft-versus-Host Disease by Devillier, Raynier, Fürst, Sabine, El-Cheikh, Jean, Castagna, Luca, Harbi, Samia, Granata, Angela, Crocchiolo, Roberto, Oudin, Claire, Mohty, Bilal, Bouabdallah, Reda, Chabannon, Christian, Stoppa, Anne-Marie, Charbonnier, Aude, Broussais-Guillaumot, Florence, Calmels, Boris, Lemarie, Claude, Rey, Jèrôme, Vey, Norbert, Blaise, Didier

“…Abstract Nonmyeloablative (NMA) regimens allow the use of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients considered unfit for…”
Get full text

The effects of bortezomib on bone disease in patients with multiple myeloma by Mohty, Mohamad, Malard, Florent, Mohty, Bilal, Savani, Bipin, Moreau, Philippe, Terpos, Evangelos

“…Bortezomib has demonstrated substantial activity in the treatment of patients with multiple myeloma and is widely incorporated into treatment strategies across…”
Get full text

Long Term Analysis of a Monocentric Cohort of Therapy-Related Acute Lymphoblastic Leukemia by Garciaz, Sylvain, Soua, Amel, Rahal, Ilhem, Hospital, Marie Anne, Saillard, Colombe, Hicheri, Yosr, Mohty, Bilal, D'Incan, Evelyne, Rey, Jerome, Vey, Norbert

“…Therapy related Acute Lymphoblastic Leukemia (t-ALL) refers to ALL developed in patients who have received prior cytotoxic therapies, including chemotherapies…”
Get full text

Clinical, Cytogenetic and Molecular Characterization of a 96 MDS and AML Cohort with TP53 Mutation by Duranjou, Marine, Castoldi, Cécile, Alary, Anne Sophie, Hicheri, Yosr, Saillard, Colombe, Rouzaud, Camille, Charbonnier, Aude, Mohty, Bilal, D'Incan, Evelyne, Rey, Jerome, Hospital, Marie Anne, Devillier, Raynier, Vey, Norbert, Gelsi-Boyer, Véronique, Lhoumeau, Anne-Catherine, Murati, Anne, Golesi, Florence, Mozziconacci, Marie Joelle, Ittel, Antoine, Garciaz, Sylvain

“…Introduction The last European LeukamiaNet (ELN) recommendations (Döhner H. et al. Blood. 2022) and the International Consensus Classification (ICC, Hasserjian…”
Get full text

Poor Prognosis of SRSF2 Gene Mutations in Patients Treated with Venetoclax-Azacitidine (VEN-AZA) for Newly Diagnosed Acute Myeloid Leukemia. a Multicentric Real-Life Study of 117 Patients by Berton, Guillaume, Sedaki, Bochra, Collomb, Erwann, Benachour, Sami, Loschi, Michael, Mohty, Bilal, Saillard, Colombe, Hicheri, Yosr, Rouzaud, Camille, Maisano, Valerio, Villetard, Ferdinand, D'Incan Corda, Evelyne, Charbonnier, Aude, Rey, Jerome, Hospital, Marie Anne, Ittel, Antoine, Abbou, Norman, Fanciullino, Raphaelle, Dadone-Montaudié, Bérengère, Vey, Norbert, Venton, Geoffroy, Cluzeau, Thomas, Alary, Anne Sophie, Garciaz, Sylvain

“…Introduction Spliceosomes are complexes composed of small nuclear RNA that remove introns in protein-encoding genes. Spliceosome mutations ( SRSF2, SF3B1,…”
Get full text

Poor prognosis of SRSF2 gene mutations in patients treated with VEN-AZA for newly diagnosed acute myeloid leukemia by Berton, Guillaume, Sedaki, Bochra, Collomb, Erwann, Benachour, Sami, Loschi, Michael, Mohty, Bilal, Saillard, Colombe, Hicheri, Yosr, Rouzaud, Camille, Maisano, Valerio, Villetard, Ferdinand, Corda, Evelyne D.'Incan, Charbonnier, Aude, Rey, Jerome, Hospital, Marie-Anne, Ittel, Antoine, Abbou, Norman, Fanciullino, Raphaelle, Dadone-Montaudié, Bérengère, Vey, Norbert, Venton, Geoffroy, Cluzeau, Thomas, Alary, Anne-Sophie, Garciaz, Sylvain

“…Mutations in spliceosome genes (SRSF2, SF3B1, U2AF1, ZRSR2) correlate with inferior outcomes in patients treated with intensive chemotherapy for Acute Myeloid…”
Get full text

Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients by Garciaz, Sylvain, Hospital, Marie-Anne, Alary, Anne-Sophie, Saillard, Colombe, Hicheri, Yosr, Mohty, Bilal, Rey, Jérôme, D'Incan, Evelyne, Charbonnier, Aude, Villetard, Ferdinand, Maisano, Valerio, Lombardi, Laura, Ittel, Antoine, Mozziconacci, Marie-Joelle, Gelsi-Boyer, Véronique, Vey, Norbert

“…Venetoclax (VEN) belongs the BH3-mimetic class that selectively targets BCL-2, activating apoptosis. The combination of VEN and azacitidine (AZA) has changed…”
Get full text

Venetoclax‐based non‐intensive induction followed by allogenic stem‐cell transplantation in elderly acute myeloid leukemia patients with adverse cytogenetics by Soua, Amel, Gilhodes, Julia, Iat, Alexandre, Hicheri, Yosr, Saillard, Colombe, Rouzaud, Camille, D'Incan, Evelyne, Rey, Jérôme, Mohty, Bilal, Charbonnier, Aude, Ittel, Antoine, Alary, Anne‐Sophie, Gelsi‐Boyer, Véronique, Murati, Anne, Lhoumeau, Anne‐Catherine, Devillier, Raynier, Boher, Jean‐Marie, Mozziconacci, Marie‐Joelle, Vey, Norbert, Hospital, Marie‐Anne, Garciaz, Sylvain

“…Introduction Elderly acute myeloid leukemia (AML) patients with poor‐risk cytogenetics have a poor outcome with intensive chemotherapy (IC). While Venetoclax…”
Get full text

Unrelated cord blood compared with haploidentical grafts in patients with hematological malignancies by El‐Cheikh, Jean, Crocchiolo, Roberto, Furst, Sabine, Bramanti, Stefania, Sarina, Barbara, Granata, Angela, Vai, Andrea, Lemarie, Claude, Faucher, Catherine, Mohty, Bilal, Harbi, Samia, Bouabdallah, Reda, Vey, Norbert, Santoro, Armando, Chabannon, Christian, Castagna, Luca, Blaise, Didier

“…BACKGROUND Alternative donors, such as unrelated umbilical cord blood (UCB) and related haploidentical (haplo) donors, are more and more frequently searched…”
Get full text

Cegal Protocol : Evaluation of the Feasibility of a Chemogenomic Approach to Identify Personalized Therapy for Relapse or Refractory AML Patients by Vey, Norbert, Hospital, Marie Anne, Collignon, Aude, Collette, Yves, Birnbaum, Daniel, Charbonnier, Aude, Mohty, Bilal, D'Incan, Evelyne, Rey, Jerome, Castellano, Remy, Montersino, Camille, Chaffanet, Max, Carbuccia, Nadine, Adelaide, Jose, Bouchacourt, Benjamin, Guille, Arnaud

“…Introduction : Significant improvements of leukemia free survival have been obtained over the last 30 years in AML. This progress has resulted from…”
Get full text

Allogeneic Hematopoietic Stem Cell Transplantation Improves Outcome of Patients > 60 Years with Acute Myeloid Leukemia in First Complete Remission: A 10-Year Single Center Transplantation Program Analysis by Devillier, Raynier, Rey, Jerome, Harbi, Samia, Charbonnier, Aude, Furst, Sabine, Saillard, Colombe, Granata, Angela, D'Incan, Evelyne, Faucher, Catherine, Lemarie, Claude, Legrand, Faezeh, Calmels, Boris, Maisano, Valerio, Mohty, Bilal, Chabannon, Christian, Weiller, Pierre Jean, Blaise, Didier, Vey, Norbert

“…Allogeneic hematopoietic stem cell transplantation (Allo-HSCT) is a curative option for patients with AML in first complete remission (CR1), but is limited by…”
Get full text

Allogeneic Hematopoietic Stem Cell Transplantation for Patients over 60 Years with Acute Myeloid Leukemia: A Single Center Donor Comparison by Devillier, Raynier, Furst, Sabine, Rey, Jerome, Granata, Angela, Charbonnier, Aude, Harbi, Samia, D'Incan, Evelyne, Pagliardini, Thomas, Faucher, Catherine, Lemarie, Claude, Saillard, Colombe, Legrand, Faezeh, Calmels, Boris, Mohty, Bilal, Maisano, Valerio, Chabannon, Christian, Weiller, Pierre Jean, Vey, Norbert, Blaise, Didier

“…Allogeneic hematopoietic stem cell transplantation (Allo-HSCT) is a curative option for patients with AML. However, most of them are diagnosed over 60 years of…”
Get full text

The Role of Donor CMV Serostatus on Outcome after T-Cell Replete Haplo-SCT and Post-Transplant Cyclophosphamide: A Cohort Analysis on 207 Consecutive Adult Patients by Crocchiolo, Roberto, Castagna, Luca, Furst, Sabine, Devillier, Raynier, Sarina, Barbara, Bramanti, Stefania, ElCheikh, Jean, Granata, Angela, Harbi, Samia, Morabito, Lucio, Faucher, Catherine, Rimondo, Andrea, Mohty, Bilal, Weiller, Pierre, Carlo-Stella, Carmelo, Chabannon, Christian, Bouabdallah, Reda, Santoro, Armando, Vey, Norbert, Blaise, Didier

“…INTRODUCTION. In the setting of T-cell replete haploidentical transplantation, the question about the best stem cell donor is still open. Cytomegalovirus (CMV)…”
Get full text